| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cef4f341fe4f2caf061611a818576e40 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 |
| filingDate |
2010-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63bb8dac6139abce38fbedc66e01116e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9bdb5aced41adffcf495f31a865a2954 |
| publicationDate |
2011-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2776331-A1 |
| titleOfInvention |
Liquid pharmaceutical compositions |
| abstract |
Aqueous liquid pharmaceutical composition comprising a) almotriptan and b) at least one compound selected from i) 1 '-methyl-5-((pyrrolidin-1 -ylsulfonyl)methyl)spiro[indoline-3,3'-pyrrolidin]-2-ol, and ii) 3-(2-(dimethylamino)ethyl)-5-((pyrrolidin-1 -ylsulfonyl)methyl)-1 H-indol-2-ol. |
| priorityDate |
2009-11-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |